L. Puig

591 papers receiving 17.9k citations

L. Puig's Hit Papers

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials 2018 · 470 citations
4700+5+10Years since publication50010001.5k

Peers

L. Puig
Comparison fields: 5 of 174
  • Dermatology 5.3k
  • Immunology 10.1k
  • Rheumatology 3.1k
  • Hematology 1.5k
  • Immunology and Allergy 644
Replace Alan Menter with:
Alan Menter United States
P.C.M. van de Kerkhof Netherlands
C. Paul France
Kristian Reich Germany
Wolf‐­Henning Boehncke Germany
Craig L. Leonardi United States
Frank O. Nestlé United Kingdom
Giampiero Girolomoni Italy
Alice B. Gottlieb United States
Enno Christophers Germany
L. Puig relative to Alan Menter United States Alan Menter's profile →
Citations per field
00.5×1.5×1.8×
Alan Menter · 1×
Citations per year

Countries citing papers authored by L. Puig

Since Specialization
Citations

This map shows the geographic impact of L. Puig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Puig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Puig more than expected).

Fields of papers citing papers by L. Puig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Puig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Puig. The network helps show where L. Puig may publish in the future.

Co-authors

The 25 scholars most cited alongside L. Puig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with L. Puig Line = papers co-authored together L. Puig links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 615 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
Hit paper breakdown →
20141511
2
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
Hit paper breakdown →
2013611
3
Epidemiology of atopic dermatitis in adults: Results from an international survey
Hit paper breakdown →
2018590
4
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions
Hit paper breakdown →
2010542
5
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
Hit paper breakdown →
2014510
6
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
Hit paper breakdown →
2018470
7 2014415
8 2007311
9 2017280
10 2019257
11 2017248
12 2017235
13 2014222
14 2020201
15 2014183
16 2011171
17 2014138
18 2016127
19 2015126
20 2020123

About L. Puig

L. Puig is a scholar working on Immunology, Dermatology, Rheumatology, Pathology and Forensic Medicine and Epidemiology, having authored 615 papers that have together received 18.3k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (303 papers), Dermatology and Skin Diseases (104 papers), Autoimmune Bullous Skin Diseases (53 papers), Health Systems, Economic Evaluations, Quality of Life (50 papers), Spondyloarthritis Studies and Treatments (36 papers), Pharmaceutical studies and practices (35 papers), Asthma and respiratory diseases (33 papers) and Autoimmune and Inflammatory Disorders Research (28 papers). The work is most often cited by research in Dermatology (5.3k citations), Immunology (10.1k citations), Rheumatology (3.1k citations), Hematology (1.5k citations) and Immunology and Allergy (644 citations). L. Puig has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Giampiero Girolomoni, María Teresa Fernández‐Figueras, Mark Lebwohl, Kristian Reich, Richard G. Langley, Arthur Kavanaugh, Tiago Torres, Kim Papp, C. Paul and Tsen‐Fang Tsai. Their work appears in journals such as Journal of the European Academy of Dermatology and Venereology, Journal of the American Academy of Dermatology, Dermatology and Therapy, British Journal of Dermatology and Journal of Dermatological Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact